ABBV FY2025 SEC EDGAR DEF 14A #15 of 168 in industry

AbbVie Inc. CEO pay ratio

The CEO earned $32.5M in FY2025 against median worker pay of $169,019 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
DE
Filing date
2026-03-23
Industry
Chemicals & Pharmaceuticals
Industry rank
#15/168

Data updated August 2026

Subscribe to AbbVie Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
192:1
High (Scale: 0–1000:1)
CEO pay
$32.5M
Median worker
$169,019

Answer first

AbbVie Inc.'s FY2025 CEO total of $32.5M ranks #58 of 1,423 complete filings; its 192:1 pay ratio ranks #327. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $169,019. Industry placement uses the FY2025 SIC-28 peer cohort (# 15 of 168, 92nd percentile - top 10% of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#58
$32.5M of 1,423 FY2025
Ratio rank
#327
192:1 of 1,423
Industry pct
92nd
top 10% of industry peers by pay ratio

How AbbVie Inc. ranks nationally

AbbVie Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$32,451,648 Top 4% higher than 96% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). Below this entry. $7,500,000–$10,000,000: 192 companies (13%). Below this entry. $10,000,000–$12,500,000: 139 companies (10%). Below this entry. $12,500,000–$15,000,000: 91 companies (6%). Below this entry. $15,000,000–$17,500,000: 88 companies (6%). Below this entry. $17,500,000–$20,000,000: 54 companies (4%). Below this entry. $20,000,000–$22,500,000: 24 companies (2%). Below this entry. $22,500,000–$25,000,000: 34 companies (2%). Below this entry. $25,000,000–$27,500,000: 24 companies (2%). Below this entry. $27,500,000–$30,000,000: 16 companies (1%). Below this entry. $30,000,000–$32,500,000: 10 companies (1%). This entry sits in this band. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

AbbVie Inc. vs. Chemicals & Pharmaceuticals peers

CEO total pay ($32.5M) against pay ratio (192:1) for AbbVie Inc. (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both6671929.313423760.420175591.526927422.633679253.634.5:175.8:1117:1158.3:1199.5:1CEO total payPay ratio (CEO : median worker)AbbVie Inc., CEO total pay: 32451648 · Pay ratio (CEO : median worker): 192:1AbbVie Inc.Fmc Corp, CEO total pay: 12025551 · Pay ratio (CEO : median worker): 191:1Fmc CorpDuPont de Nemours, Inc., CEO total pay: 16157988 · Pay ratio (CEO : median worker): 189:1DuPont de Nemours, Inc.Elanco Animal Health Inc, CEO total pay: 14964175 · Pay ratio (CEO : median worker): 181:1Elanco Animal Health IncCabot Corp, CEO total pay: 9307883 · Pay ratio (CEO : median worker): 171:1Cabot CorpHuntsman CORP, CEO total pay: 14649600 · Pay ratio (CEO : median worker): 168:1Huntsman CORP
AbbVie Inc. vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in AbbVie Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · AbbVie Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
192:1
FY2025
vs prior FY
+54:1
from FY2024 138:1
CEO $ YoY
+75%
$32.5M latest
Filings shown
5
FY2021–2025
AbbVie Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $23.9M - $149,662 160:1 -
2022 $26.3M +9.6% $117,189 224:1 +64:1
2023 $25.7M -2.1% $151,991 169:1 -55:1
2024 $18.5M -28% $134,351 138:1 -31:1
2025 $32.5M +75% $169,019 192:1 +54:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1551152, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
192:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$32.5M
Companies in Industry
168
vs. Industry Median
Above
#15 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

AbbVie Inc.: STEEP · PEAK pay ratio

AbbVie Inc.'s FY2025 ratio 192:1 ranks #15 of 168 Chemicals & Pharmaceuticals filers (92nd percentile). the CEO earned 192× the median employee ($169,019) in FY2025.

Median employee $169,019 (ELITE-MED); STEEP · PEAK stamps put about 192 median-wage years per CEO year.

CEO Total Pay

$32.5M

FY2025 Summary Compensation, well above median

Pay Ratio

192:1

Elevated vs. peers

AbbVie Inc. in the higher Chemicals & Pharmaceuticals third

AbbVie Inc.'s FY2025 ratio 192:1 ranks #15 of 168 Chemicals & Pharmaceuticals filers (92nd percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; AbbVie Inc.'s $32.5M CEO total is above the $7.9M industry median CEO pay.

Dollar rank #58 and ratio rank #327 split - treat 192:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$32.5M
Median Employee Pay
$169,019
Pay Ratio
192:1
Filing Date
2026-03-23

Company Info

Ticker
ABBV
CIK
1551152
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 1551152, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. AbbVie Inc.'s FY2025 ratio 192:1 ranks #15 of 168 Chemicals & Pharmaceuticals filers (92nd percentile).

Read with AbbVie Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps STEEP · PEAK · ELITE-MED.

Live Nation Entertainment, Inc. · PEAK

ABS(ceo_total_comp) peer at $32.6M (Δ $101K heavier vs AbbVie Inc.); EXTREME · LOW-MED vs this page's STEEP · PEAK · ELITE-MED.
United Airlines Holdings, Inc. · PEAK

ABS(ceo_total_comp) peer at $32.3M (Δ $169K lighter vs AbbVie Inc.); HIGH · HIGH-MED vs this page's STEEP · PEAK · ELITE-MED.
Tractor Supply Co /de/ · PEAK

ABS(ceo_total_comp) peer at $32.3M (Δ $178K lighter vs AbbVie Inc.); MEGA · LOW-MED vs this page's STEEP · PEAK · ELITE-MED.
Baxter International Inc · PEAK

ABS(ceo_total_comp) peer at $32.2M (Δ $233K lighter vs AbbVie Inc.); HIGH · HIGH-MED vs this page's STEEP · PEAK · ELITE-MED.
Fmc Corp (SIC 28 pole)

Fmc Corp stamps STEEP · HEAVY nearest in-SIC by ABS(pay_ratio) to AbbVie Inc.'s STEEP filing.
National dual ranks · #58/#327

AbbVie Inc.'s FY2025 package sits #58 by CEO dollars and #327 by ratio under PEAK · STEEP.
Comp structure · PEAK

AbbVie Inc.'s PEAK CEO total is equity-sensitive - read what grant-date fair value does and does not mean.
Data sourced from SEC EDGAR DEF 14A for AbbVie Inc. (CIK 1551152), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.